Haiying Cheng Selected Research

Complement System Proteins (Complement)

9/2017	Circulating DNA in EGFR-mutated lung cancer.
2/2008	Blood-flow magnetic resonance imaging of the retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haiying Cheng Research Topics

Disease

32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2010
28	Lung Neoplasms (Lung Cancer) 12/2023 - 02/2013
23	Neoplasms (Cancer) 12/2023 - 03/2012
6	Hypoglycemia (Reactive Hypoglycemia) 12/2008 - 06/2006
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
3	Disease Progression 11/2023 - 01/2017
3	Adenocarcinoma of Lung 01/2018 - 03/2015
2	Inflammation (Inflammations) 01/2023 - 02/2018
2	Adenocarcinoma 01/2018 - 02/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2012 - 07/2011
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2008 - 06/2006
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Infantile Spasms (West Syndrome) 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Female Infertility 01/2023
1	Infertility (Sterility) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Meningitis 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Thyrotoxicosis 03/2021
1	Gastritis 02/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Vitiligo 10/2017
1	Melanoma (Melanoma, Malignant) 10/2017
1	Halo Nevus 10/2017
1	Epilepsy (Aura) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2006
6	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 04/2013
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2013
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2008
5	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
4	osimertinibIBA 01/2024 - 01/2018
4	durvalumabIBA 01/2024 - 03/2021
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2014
4	Epinephrine (Adrenaline)FDA LinkGeneric 12/2008 - 09/2007
3	PlatinumIBA 01/2022 - 04/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2013
3	AntibodiesIBA 01/2020 - 04/2012
3	AMP-Activated Protein KinasesIBA 10/2013 - 06/2006
3	Hypoglycemic Agents (Hypoglycemics)IBA 12/2008 - 09/2007
3	Retinaldehyde (Retinal)IBA 11/2008 - 04/2006
3	Glucagon (Glukagon)FDA Link 05/2008 - 09/2007
2	pembrolizumabIBA 11/2023 - 06/2020
2	CrizotinibIBA 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 05/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 01/2018
2	Cell-Free Nucleic AcidsIBA 01/2018 - 09/2017
2	Circulating Tumor DNAIBA 11/2017 - 09/2017
2	Complement System Proteins (Complement)IBA 09/2017 - 02/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 01/2017
2	UrocortinsIBA 10/2013 - 06/2006
2	Corticotropin-Releasing HormoneIBA 10/2013 - 09/2007
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 10/2013 - 09/2007
2	Gemcitabine FDA Link 03/2012 - 07/2011
2	Insulin (Novolin)FDA Link 12/2008 - 06/2006
1	Pyruvate Dehydrogenase (Lipoamide)IBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	fibroblast growth factor 13IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	EnzymesIBA 01/2023
1	B7-H1 AntigenIBA 09/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	thiazolyl blueIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	lorlatinibIBA 01/2022
1	AfatinibIBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	Albumin-Bound Paclitaxel FDA Link 01/2019
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 02/2018
1	Therapeutic UsesIBA 02/2018
1	brigatinibIBA 01/2018
1	Immune Checkpoint ProteinsIBA 01/2018
1	alectinibIBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 01/2018
1	atezolizumabIBA 10/2017
1	LigandsIBA 10/2017

Therapy/Procedure

25	Therapeutics 11/2023 - 06/2006
10	Immunotherapy 12/2023 - 02/2017
9	Drug Therapy (Chemotherapy) 01/2022 - 03/2012
4	Chemoradiotherapy 11/2023 - 03/2021
3	Radiotherapy 11/2023 - 01/2017
1	Radioimmunotherapy 11/2023
1	Combined Modality Therapy 01/2023
1	Wearable Electronic Devices 11/2019
1	Acupuncture Points (Acupuncture Point) 02/2018
1	Percutaneous Collagen Induction 02/2018
1	Investigational Therapies (Experimental Therapy) 04/2017
1	Drug Tapering 03/2016